What changes when we fulfil the dream of living longer?
mehr
Storys zum Thema Health
Takeda Receives Positive CHMP Opinion Recommending Approval of Lanadelumab for Routine Prevention of Recurrent Attacks of Hereditary Angioedema (HAE) in Patients Aged 2 years and Older
Zurich (ots/PRNewswire) - - If Approved, Lanadelumab Will be the First Long-Term Prophylactic Treatment of HAE Available in the EU for Patients Under the Age of Six. - Positive Opinion Based on Pivotal Study SHP643-301, Evaluating the Safety Profile and Pharmacokinetics (PK) of Lanadelumab, in Combination with ...
mehrSilony Medical International AG
Silony Medical acquires Centinel Spine's Global Fusion Business
Frauenfeld, Switzerland (ots/PRNewswire) - The transaction includes all cervical and lumbar fusion products, including the STALIF® technology platform Silony Medical International AG (the company), a growing challenger to "big medtech" in the global spinal fusion market, has signed a definitive agreement to acquire Centinel Spine's Global Fusion Business. This combines Silony's Verticale® posterior screw & rod fusion ...
mehrLatest Sports & Fitness Innovation: Holistic Training Syllabus by MAVERICKS Life Co.
CRANS-MONTANA, Switzerland (ots/PRNewswire) - Sports science & wellbeing education company, MAVERICKS Life Co., announces the release of its new Holistic Training Syllabus, rooted in evolutionary biology and epigenetics theory. It's a brand new innovation in the sports and fitness sector. Recent scientific studies* have led to groundbreaking development that is ...
mehrLabguru (BioData) Partners with SAP to Provide its Lab Data Management Solution via the SAP Store
Boston (ots/PRNewswire) - BioData today revealed that Labguru, its all-encompassing Lab Data Management solution, is now accessible on SAP® Store, the digital marketplace for SAP and Software Partner Providers. The addition to the SAP store will increase the ease with which customers can access Labguru, ensuring ...
mehrNorgine Strengthens Senior Leadership with the Appointment of Saulo Martiniano as Chief Operating Officer
Amsterdam (ots/PRNewswire) - Norgine, a leading European specialist pharmaceutical company dedicated to improving the lives of patients, is pleased to announce the appointment of Saulo Martiniano as its new Chief Operating Officer (COO). Saulo joins Norgine with a wealth of experience and a unique blend of ...
mehrIsotopia Issues a call to action to the radionuclide Therapy industry.
Petah Tikva, Israel (ots/PRNewswire) - Isotopia Molecular Imaging is a global pharmaceutical company that develops, produces, and distributes therapeutic and diagnostic radioactive isotopes. "If you are in the Lu-177 field, don't miss this information." The Lu-177 radiopharmaceuticals sector stands at a critical juncture, necessitating urgent collaboration. Our shared ...
mehrSignia Introduces Hearing Aids That Tackle the Most Difficult Challenge for People With Hearing Loss: Group Conversations in Noise
Lynge, Denmark (ots/PRNewswire) - Hearing aid innovator Signia, part of WS Audiology, today launches Integrated Xperience, a breakthrough technology that enables hearing aid wearers to hear all speakers in noisy group conversations clearly. Even when speakers move or the wearer turns their head, the hearing aids ...
mehrCOP28 Presidency urges adaptation efforts at Korea Global Adaptation Week
Incheon, South Korea (ots/PRNewswire) - - Ambassador Majid Al Suwaidi, Director-General and Special Representative of COP28, stressed the urgency of delivering a robust Framework on the Global Goal on Adaptation - He reiterated the call for developed countries to uphold their commitment to doubling adaptation finance by 2025. - The Global Stocktake at COP28 will enable ...
mehrJohnson & Johnson Vision announces launch of ELITA™ Platform to Correct Myopia with New SILK Procedure at the European Society of Cataract and Refractive Surgeons Congress
London (ots/PRNewswire) - Next-generation laser vision correction provides next-day results and recovery1,2 - The next-generation ELITATM Femtosecond Laser to correct myopia with the new SILK procedure** - The latest innovation in extended depth of focus (EDOF) intraocular lenses (IOLs) will be shared with invited ...
mehrHuma collaborates with Google Cloud to improve healthcare through generative AI
New York (ots/PRNewswire) - - Huma aims to further support patients and the healthcare workforce by enhancing its regulated Software as Medical Device (SaMD) platform with the addition of generative AI applications - Huma is leveraging Google Cloud's Vertex AI platform and exploring the use of other Google GenAI tools such as Med-PaLM 2 - Huma and Google Cloud are ...
mehrSuccessful FDA inspection at Aurisco's manufacturing site in Yangzhou, China
Yangzhou, China (ots/PRNewswire) - Aurisco Pharmaceutical today announced that its cGMP manufacturing plant in Yangzhou has successfully passed a USFDA inspection. Aurisco Pharmaceutical announced today that its API and FDF plant in Yangzhou, China has successfully passed a cGMP inspection by the US Food and Drug Administration (USFDA). The inspection, carried out by ...
mehrCartiHeal Announces First Commercial Implantation of Agili-C™ in the US
Kfar Saba, Israel (ots/PRNewswire) - CartiHeal Ltd., developer of implants for the treatment of cartilage and osteochondral defects in arthritic and non-arthritic knee-joints, today announced its first commercial implantation of Agili-C in the US by Dr. Ken Zaslav, a specialist in Orthopedic Surgery and Sports Medicine at Northwell Health in New York City, NY. The ...
mehrPRODUCTLIFE GROUP ACQUIRES RNI, EXPANDING ITS SCIENTIFIC AND REGULATORY OFFERING TO SELFCARE PRODUCTS
Paris (ots/PRNewswire) - ProductLife Group, a global provider of regulatory and compliance services for the life sciences industry, strengthens its regulatory expertise in borderline products with the acquisition of RNI, a consulting firm providing global regulatory and scientific services across the entire spectrum ...
mehrD&A Pharma : Despite the latest alarming figures on alcohol dependence, France is delaying the use of sodium oxybate, which has been prescribed for almost 30 years in Italy and Austria
Paris (ots/PRNewswire) - At the beginning of June, the health authorities hammered it home once again: "The health, social and economic consequences of alcohol consumption represent a burden for French society." The results are alarming: every year in France, alcohol is the cause of 49,000 deaths and an estimated ...
mehrREVEAL GENOMICS® ANNOUNCES POSITIVE TOP-LINE RESULTS FOR HER2DX® IN MEDSIR'S PHERGAIN TRIAL
Barcelona, Spain (ots/PRNewswire) - - HER2DX® pCR-score was significantly associated with pathological complete response in patients with HER2+ breast cancer treated with trastuzumab and pertuzumab, with or without chemotherapy. - HER2DX® risk-score identified 85% of patients with an invasive disease event as ...
mehrCroma-Pharma announces enrollment of first patient in hyaluronic acid dermal filler clinical trial in China
Vienna (ots/PRNewswire) - Croma-Pharma® ('Croma') announced today that in June the first patient will be enrolled in the clinical trial1 for the approval of its hyaluronic acid dermal filler Princess® Volume Plus Lidocaine2 in China. The randomised, multi-centre, evaluator blinded, parallel group, active ...
mehrHuma receives multi-condition US FDA 510(k) Class II regulatory clearance for its configurable SaMD disease management platform
New York and London (ots/PRNewswire) - - Class II clearance expands the patient population that can be managed - Companies working with Huma's platform can now launch algorithm innovations more quickly in a compliant and de-risked manner, democratising digital health innovation across the industry - Clearance was ...
mehrMetaporta and Merantix launch partnership to build AI platform
Basel (ots) - The Venture Studio Metaporta launches a partnership with Merantix AI Campus Berlin to build a global hub for AI solutions in life sciences and healthcare in Allschwil/Basel. Artificial Intelligence (short: AI) holds an immense potential to create solutions in industries across the board. The Basel region, as Europe's leading life sciences cluster, already struggles with a shortage of IT professionals, and ...
mehrCroma-Pharma: Launch of topical anaesthetic Pliaglis® in Europe
Vienna (ots/PRNewswire) - Croma-Pharma, a global player and challenger in the dynamically growing, minimally invasive aesthetics market, announces that it will launch Pliaglis®, a topical local anaesthetic for superficial dermatological procedures, in its European core markets including Germany, the United Kingdom ("UK"), and Ireland. Further markets including Brazil will follow by the end of 2023. The anaesthetic cream ...
mehrHuma named for its successful and innovative approach to clinical trials in new UK government review
New York and London (ots/PRNewswire) - - Huma's innovative approach to medical research cited in Lord James O'Shaughnessy's review for clinical trials improvement in the UK - The review is part of a new widespread policy approach to ignite the UK's life sciences sector - Innovating clinical trials using digital technologies such as Huma's platforms can make them more ...
mehrDeep Breath Intelligence Teams with HTEC Group and Effectum Medical to Accelerate the Launch of CE-marked device under IVDD
Belgrade, Serbia (ots/PRNewswire) - Deep Breath Intelligence (DBI), a MedTech company unleashing the huge potential of exhaled breath analysis through machine learning, has selected HTEC Group and Effectum Medical as primary innovation facilitators to help them achieve greater speed in meeting both software and ...
mehrEuropean study highlights need to improve the quality of conversations about induction of labour (IoL) in clinical settings
Amsterdam (ots/PRNewswire) - - Almost 1 in 2 women (49%) felt the experience of IoL differed from their expectations - The majority of expectant mothers (65%) did not feel fully involved in choosing which method of IoL they prefer - Findings emphasize the importance of collaborative decision-making between ...
mehrDEBIOPHARM LAUNCHES PHASE 1/2 COMBINATION TRIAL INVESTIGATING BRAIN-PENETRANT SELECTIVE WEE1 INHIBITOR FOR BRAIN CANCER PATIENTS
Lausanne (ots) - - Glioblastomas (GBM) are among the most aggressive and lethal tumors of the central nervous system with a 5-year survival rate of only 6.8%. - Debiopharm is combining its potent, brain penetrant WEE1 inhibitor Debio 0123 with standard of care (SOC) therapy. Debio 0123 hopes to hinder DNA damage ...
mehrSchweizerischer Nationalfonds / Fonds national suisse
Transition to a sustainable economy: policy recommendations
Bern (ots) - How can economic progress be aligned with social and environmental responsibility? In closing, the National Research Programme "Sustainable Economy" (NRP 73) presents recommendations in this regard. To mark its conclusion, the National Research Programme "Sustainable Economy: resource-efficient, future-oriented, innovative" (NRP 73) is presenting a white paper with recommendations to policymakers for the ...
mehr/C O R R E C T I O N -- Croma-Pharma/
Vienna (ots/PRNewswire) - In the news release, Croma-Pharma reports 27% revenue growth in 2022 and targets further revenue growth in 2023 and thereafter, issued 09-May-2023 by Croma-Pharma over PR Newswire, we are advised by the company that the footnote [1] has been updated. The complete, corrected release follows: Croma-Pharma reports 27% revenue growth in 2022 and targets further revenue growth in 2023 and thereafter - ...
mehrCroma-Pharma reports 27% revenue growth in 2022 and targets further revenue growth in 2023 and thereafter
Vienna (ots/PRNewswire) - - Company reports strong financial results for 2022 with 27% revenue growth in 2022 and significantly increased margins - Growth driven by launch of Letybo® and its catalytic effect on the existing portfolio as well as strong market growth - Continued market share gains, strategic mid-term ...
mehrHovione and H&T Presspart extend partnership to advance high efficiency device technology for Dry Powder Inhalation formulation delivery
Lisbon, Portugal (ots/PRNewswire) - Hovione, the specialist integrated CDMO, leader in spray drying and particle engineering, and H&T Presspart have entered in a strategic partnership to advance the development of Presspart's Sunriser© Capsule-based Dry Powder Inhaler platform. The demand for inhalable drugs that ...
mehrHuma and UCB partner to provide digital health solution to improve management of the rare disease, Myasthenia gravis
New York and London (ots/PRNewswire) - - Project aims to improve patient outcomes through better clinical management of disease exacerbations using self-reported data - Exciting opportunity to improve education and empowerment and for patients to be active participants in their own care - Huma's EU MDR Class IIb ...
mehrAurisco Expands Oligonucleotide Capacity and Launches New Website
SETÚBAL, Portugal (ots/PRNewswire) - The New State-of-Art OligoPilot 2000™ solid-phase synthesizer adds cGMP manufacturing capacity to support and accelerate clinical and commercial oligonucleotide programs. The new website shows how R&D and Innovation is the driving force of its sustainable growth, featuring its technologies, capabilities, services and products, including Oligonucleotides, peptides and small molecules ...
mehr
12345678910Nächste